SCHEMBL18797243

SCHEMBL18797243

C=C(C(=O)O)C(C=C(CCCC)C(=O)O)CC(NC)(NC)NC

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8350923 0.81 APEX1 (0.35) APEX1
SCHEMBL8355107 0.76 GPR84 (0.40)
SCHEMBL7879109 0.74 FFAR4 (0.39) APEX1
SCHEMBL4442361 0.74 FFAR1 (0.42)
SCHEMBL8769847 0.74 ACHE (0.35)
SCHEMBL158481 0.73 APEX1 (0.36) APEX1
SCHEMBL7017093 0.71 FFAR3 (0.32)
SCHEMBL7262843 0.71 DNM1 (0.37) APEX1
SCHEMBL6696578 0.71 CAMK2A (0.32)
SCHEMBL9234963 0.70 ACHE (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368205-B1 MICROCAPSULES AND COMPOSITIONS PROVIDING CONTROLLED RELEASE OF ACTIVES NOXELL CORP (US) 2021-06-30 EP disclosed
US-10653592-B2 Microcapsules and compositions providing controlled release of actives NOXELL CORPORATION (US) 2020-05-19 US disclosed
US-20180289597-A1 MICROCAPSULES AND COMPOSITIONS PROVIDING CONTROLLED RELEASE OF ACTIVES JPMORGAN CHASE BANK, N.A. 2018-10-11 US disclosed
EP-3368205-A1 MICROCAPSULES AND COMPOSITIONS PROVIDING CONTROLLED RELEASE OF ACTIVES Noxell Corporation (US) 2018-09-05 EP disclosed
WO-2017075074-A1 MICROCAPSULES AND COMPOSITIONS PROVIDING CONTROLLED RELEASE OF ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2017-05-04 WO disclosed